Education
About Us
Working with TipRanks
Follow Us
Fate Therapeutics (FATE)
NASDAQ:FATE
Trastuzumab, Paclitaxel, Cetuximab, Ft836
Ovarian Cancer, Colorectal Cancer, Non-small Cell Lung Cancer, Breast Cancer, Head And Neck Squamous Cell Carcinoma, Endometrial Carcinoma
Phase I
Recruiting
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Oct 08, 2025
―
Bendamustine, Cyclophosphamide, Fludarabine, Ft819
Systemic Lupus Erythematosus (Sle), Systemic Sclerosis (Ssc), Antineutrophilic Cytoplasmic Antibody (Anca)- Associated Vasculitis (Aav), Idiopathic Inflammatory Myositis (Iim)
Phase I
Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Mar 06, 2024
―
Bendamustine, Docetaxel, Cyclophosphamide, Fludarabine, Cisplatin, Cetuximab, Ft825
Advanced Solid Tumor
Phase I
Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
Jan 27, 2024
―
Rituximab, Bendamustine, Cyclophosphamide, Fludarabine, Ft522
Relapsed/Refractory B-Cell Lymphoma
Phase I
Completed
FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)
Jul 10, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Fate Therapeutics (FATE) have in its pipeline
FATE is currently developing the following drugs: Trastuzumab, Paclitaxel, Cetuximab, Ft836, Bendamustine, Cyclophosphamide, Fludarabine, Ft819, Bendamustine, Docetaxel, Cyclophosphamide, Fludarabine, Cisplatin, Cetuximab, Ft825. These drug candidates are in various stages of clinical development as the company works toward FDA approval.